NLH Eyes & Vision Specialist Library Presents The - Annual Evidence Update On Glaucoma, 24th To 30th November 2008 | OphthalmologyWeb: The Ultimate Online Resource for Ophthalmologists

Tuesday, November 25, 2008

Email

Comments

Medical News Today

The term "glaucoma" for the purposes of the annual evidence update (AEU) is used to cover primary open angle glaucoma (POAG) and normal tension glaucoma (NTG). Ocular hypertension is also included here as it is a strong risk factor for developing glaucoma.

Glaucoma Testing Equipment / Glaucoma Products »

All of the following drugs are FDA approved for the treatment of minimally classic subfoveal CNV in patients with neovascular AMD with evidence of recent disease progression (loss of vision, growth of CNV on FA, new macular hemorrhage) except for which one?
1. Pegaptanib sodium (Macugen)
2. Verteporfin (Visudyne PDT)
3. Ranibizumab (Lucentis)
4. None of the above
5. All of the above
Check The Answer

CIRRUS™ HD-OCT 5000 with FastTrac™ - The Clinical Powerhouse
CIRRUS HD-OCT 5000 is configured with ... view product
3nethra classic Ophthalmic Imaging Device
The 3nethra classic is a compact, ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us